Aberrant DNA methylation in non-small cell lung cancer-associated fibroblasts

Carcinogenesis

Volumn 36, Issue 12, 2015, Pages 1453-1463

  Vizoso, Miguel ^a   Puig, Marta ^b,c   Carmona, F Javier ^a   Maqueda, Maria ^d   Velásquez, Adriana ^b   Gómez, Antonio ^a   Labernadie, Anna ^e   Lugo, Roberto ^b   Gabasa, Marta ^b   Rigat Brugarolas, Luis G ^d,e   Trepat, Xavier ^b,e,f   Ramirez, Josep ^c   Moran, Sebastian ^a   Vidal, Enrique ^a   Reguart, Noemi ^c   Perera, Alexandre ^d   Esteller, Manel ^a,f   Alcaraz, Jordi ^b,g  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^e INSTITUTE FOR BIOENGINEERING OF CATALONIA IBEC   (Spain)

^f INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; MICRORNA; SMAD3 PROTEIN; SMAD3 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA1;

ADENOCARCINOMA; DNA METHYLATION; DNA SEQUENCE; EXTRACELLULAR MATRIX; FIBROBLAST; FOCAL ADHESION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; HUMAN; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DNA METHYLATION; EPIGENESIS, GENETIC; EXTRACELLULAR MATRIX; FIBROBLASTS; FOCAL ADHESIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; RECEPTORS, IGG; SEQUENCE ANALYSIS, DNA; SMAD3 PROTEIN; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED;

EID: 84949755236     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgv146     Document Type: Article

References (50)

1. Chen, Z. et al. (2014) Non-small-cell lung cancers: a heterogeneous set of diseases. Nat. Rev. Cancer, 14, 535-546.
2. Bissell, M.J. et al. (2012) Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat. Med., 17, 320-329.
3. Polyak, K. et al. (2009) Co-evolution of tumor cells and their microenvironment. Trends Genet., 25, 30-38.
4. Ohlund, D. et al. (2014) Fibroblast heterogeneity in the cancer wound. J. Exp. Med., 211, 1503-1523.
5. Navab, R. et al. (2011) Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. Proc Natl Acad Sci USA, 108, 7160-7165.
6. Puig, M. et al. (2015) Matrix stiffening and beta(1) integrin drive subtype-specific fibroblast accumulation in lung cancer. Mol. Cancer Res., 13, 161-173.
7. Bertolini, G. et al. (2009) Highly tumorigenic lung cancer CD133(+) cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA, 106, 16281-16286.
8. Hu, M. et al. (2005) Distinct epigenetic changes in the stromal cells of breast cancers. Nat. Genetics, 37, 899-905.
9. Hinz, B. et al. (2012) Recent developments in myofibroblast biology. Paradigms for connective tissue remodeling. Am. J. Pathol., 180, 16.
10. Heyn, H. et al. (2012) DNA methylation profiling in the clinic: applications and challenges. Nat. Rev. Genetics, 13, 679-692.
11. Pogribny, I.P. et al. (2009) DNA hypomethylation in the origin and pathogenesis of human diseases. Cell. Mol. Life Sci., 66, 2249-2261.
12. Hanahan, D. et al. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646-674.
13. Sandoval, J. et al. (2013) A prognostic DNA methylation signature for stage i non-small-cell lung cancer. J. Clin. Oncol., 31, 4140.
14. Lin, S.H. et al. (2014) Genes suppressed by DNA methylation in nonsmall cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition. BMC Genomics, 15, 1079.
15. Jiang, L. et al. (2008) Global hypomethylation of genomic DNA in cancer-associated myofibroblasts. Cancer Res., 68, 9900-9908.
16. Abramoff, M.D. et al. (2004) Image processing with ImageJ. Biophotonics Int., 11, 36-42.
17. Sandoval, J. et al. (2011) Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics, 6, 692-702.
18. Ritchie, M.E. et al. (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res., 43, e47.
19. Yu, G. et al. (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. Omics, 16, 284-287.
20. Kanehisa, M. et al. (2000) KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res., 28, 27-30.
21. Croft, D. et al. (2014) The Reactome pathway knowledgebase. Nucleic Acids Res., 42, D472-D477.
22. Ashburner, M. et al. (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet., 25, 25-29.
23. Alexa, A. et al. (2006) Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics, 22, 1600-1607.
24. Zhang, J.D. et al. (2009) KEGGgraph: a graph approach to KEGG PATHWAY in R and bioconductor. Bioinformatics, 25, 1470-1471.
25. Kandasamy, K. et al. (2010) NetPath: a public resource of curated signal transduction pathways. Genome Biol., 11.
26. Javier Carmona, F. et al. (2013) DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer. Cancer Prev. Res., 6, 656-665.
27. van der Straaten, H.M. et al. (2004) Extra-dornain-a fibronectin: a new marker of fibrosis in cutaneous graft-versus-host disease. J. Invest. Dermatol., 123, 1057-1062.
28. Livak, K.J. et al. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
29. Serra-Picamal, X. et al. (2012) Mechanical waves during tissue expansion. Nat. Phys., 8, 628-666.
30. Roca-Cusachs, P. et al. (2008) Micropatterning of single endothelial cell shape reveals a tight coupling between nuclear volume in G1 and proliferation. Biophys. J., 94, 4984-4995.
31. Okayama, H. et al. (2012) Identification of genes upregulated in ALKpositive and EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res., 72, 100-111.
32. Kalluri, R. et al. (2006) Fibroblasts in cancer. Nat. Rev. Cancer, 6, 392-401.
33. Strieter, R.M. et al. (2009) The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis. Trans. Am. Clin. Climatol. Assoc., 120, 49-59.
34. Bellini, A. et al. (2007) The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab. Invest., 87, 858-870.
35. Sun, X. et al. (2013) The epigenetic feedback loop between DNA methylation and microRNAs in fibrotic disease with an emphasis on DNA methyltransferases. Cell. Signal., 25, 1870-1876.
36. Ashcroft, G.S. et al. (1999) Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat. Cell Biol., 1, 260-266.
37. Shakya, R. et al. (2013) Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. Cancer Res., 73, 885-896.
38. Karouzakis, E. et al. (2009) DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheumat., 60, 3613-3622.
39. Hu, B. et al. (2010) Epigenetic regulation of myofibroblast differentiation by DNA methylation. Am. J. Pathol., 177, 21-28.
40. Huang, S.K. et al. (2012) Prostaglandin E2 increases fibroblast gene-specific and global DNA methylation via increased DNA methyltransferase expression. FASEB J., 26, 3703-3714.
41. Teicher, B.A. (2001) Malignant cells, directors of the malignant process: role of transforming growth factor-beta. Cancer Metast. Rev., 20, 133-143.
42. Quante, M. et al. (2011) Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell, 19, 257-272.
43. Berdasco, M. et al. (2010) Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev. Cell, 19, 698-711.
44. Wilson, A.S. et al. (2007) DNA hypomethylation and human diseases. Biochimica Et Biophysica Acta Reviews on Cancer, 1775, 138-162.
45. Ito, Y. et al. (2015) The RUNX family: developmental regulators in cancer. Nat. Rev. Cancer, 15, 81-95.
46. Samanta, D. et al. (2012) Smoking attenuates transforming growth factor-beta-mediated tumor suppression function through downregulation of Smad3 in lung cancer. Cancer Prev. Res., 5, 453-463.
47. Hinz, B. (2007) Formation and function of the myofibroblast during tissue repair. J. Invest. Dermatol., 127, 526-537.
48. Hu, B. et al. (2003) Smad3 mediates transforming growth factor-betainduced alpha-smooth muscle actin expression. Am. J. Respir. Cell Mol. Biol., 29, 397-404.
49. Peng, H. et al. (2012) Fibrocytes: emerging effector cells in chronic inflammation. Curr. Opin. Pharmacol., 12, 491-496.
50. Headon, D.J. et al. (2001) Gene defect in ectodermal dysplasia implicates a death domain adapter in development. Nature, 414, 913-916.